Search clinical trials for: Septal Occluder Device

Total 9323 results

Abbott Medical Devices

Terminated

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study (ASO 522)

Atrial Septal Defect Secundum

United States
University of Sao Paulo
W.L.Gore & Associates; InCor Heart Institute

Terminated

Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device (TEFGoreHelex)

Acquired Tracheo-esophageal Fistula

Brazil
Carag AG

Completed

Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale

Atrial Septal Defect | Patent Foramen Ovale

Germany
Abbott Medical Devices

Completed

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Atrial Septal Defect

United States
W.L.Gore & Associates

Recruiting

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder (GSO-PFO PMS)

Stroke | TIA | Cryptogenic Stroke | PFO - Patent Foramen Ovale

Japan
W.L.Gore & Associates

Completed

Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Septal Defect, Atrial

United States
W.L.Gore & Associates

Completed

Long-term Safety Study of the GORE® HELEX® Septal Occluder

Septal Defect, Atrial

United States
Chinese Academy of Medical Sciences, Fuwai Hospital

Not yet recruiting

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine (BioMetal)

Migraine | Migraine Headache | PFO - Patent Foramen Ovale | Migraine Headache, With or Without Aura

China
University Health Network, Toronto
St. Paul's Hospital, Canada; Montreal Heart Institute; Centre de Recherche de...

Recruiting

Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study (Trio-ASD)

Atrial Septal Defect

Canada
W.L.Gore & Associates

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

Stroke | PFO - Patent Foramen Ovale

United States
Abbott Medical Devices

Active, not recruiting

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study (VPA)

Ventricular Septal Defects

United States, Canada
pfm medical ag
Aix Scientifics

Completed

Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System (pfm-01/2005)

Heart Septal Defects, Ventricular

Germany, Israel
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
Nobles Medical Technologies II Inc

Enrolling by invitation

Stitch Closure of PFO and Septal Repair (STITCH)

Foramen Ovale, Patent | Septal Defect, Atrial | Septal Defect, Heart

United States, Italy
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - AMPLATZER Duct Occluder

Patent | Ductus | Arteriosus
W.L.Gore & Associates

Completed

GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients (REDUCE)

Stroke | Transient Ischemic Attack

United States, Denmark
Abbott Medical Devices

Approved for marketing

Emergency/Compassionate Use PFO Occluder

Patent Foramen Ovale | PFO
Abbott Medical Devices

No longer available

PFO ACCESS Registry

Stroke | Patent Foramen Ovale
Gachon University Gil Medical Center

Completed

Residual Shunt After Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke

Patent Foramen Ovale | Closure; Foramen Ovale

Korea, Republic of
Abbott Medical Devices

Completed

Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder

Heart Septal Defects, Ventricular

United States
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - Membranous VSD Occluder

Membranous | Ventricular | Septal | Defects | VSD
Abbott Medical Devices

Completed

Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder

Patent Ductus Arteriosus (PDA)

United States
Rambam Health Care Campus

Unknown

Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention

A Known Allergy to Antiseptic Soap | Women Who Had Any Infection in the Perioperative Period | A Known Allergy to Chlorohexidine Alcohol or Shellfis
SeptRx, Inc.

Unknown

InterSEPT: In-Tunnel SeptRx European PFO Trial (InterSEPT)

Heart Septal Defects | Heart Defects, Congenital | Foramen Ovale, Patent

Germany, France
Occlutech International AB

Completed

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation (OLAAC)

Atrial Fibrillation

Germany, United Kingdom
Conformal Medical, Inc

Suspended

The CONFORM Pivotal Trial

Stroke | Atrial Fibrillation

United States, Georgia, Uzbekistan
China National Center for Cardiovascular Diseases

Recruiting

Cerebral Microembolization Associated With PFO Closure

Thrombosis Cardiac

China
Angela Bianco
Icahn School of Medicine at Mount Sinai

Completed

Dental Support Device in the Second Stage of Labor

Labor

United States
Carag AG

Completed

Safety and Effectiveness Study of the Solysafe Septal Occluder

Atrial Septal Defects

Serbia
Carag AG

Completed

FIH Study With CBSO

Atrial Septal Defect (ASD) | Patent Foramen Ovale (PFO)

Germany
Queen's University

Completed

The Retention Rate Between Brand A and Brand B Punctal Plugs

Dry Eye

Canada
pfm S.R.L.

Completed

Safety and Effectiveness of the Device "Nit-Occlud® PDA-R"

Congenital Heart Disease

Bolivia
Ya-Wei Xu
West China Hospital; Ruijin Hospital; Shanghai Ninth People's Hospital Affiliated... and other collaborators

Unknown

Study of Safety and Efficacy of a Left Atrial Appendage Occulder

Stroke | Non-valvular Atrial Fibrillation
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Neurovalens Ltd.
University College Dublin; Exploristics Ltd; Compliance Solutions Ltd.

Completed

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

Metabolic Syndrome | Type 2 Diabetes

Ireland
W.L.Gore & Associates

Completed

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms (TAMBE)

Thoracoabdominal Aortic Aneurysm

United States
Neurovalens Ltd.
University College Dublin; Clinical Trial Mentors; CS Lifescience

Active, not recruiting

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Improving Glycemic Control in Adults With Type 2 Diabetes Mellitus

Type 2 Diabetes

United States, Ireland
Dartmouth-Hitchcock Medical Center
American Gastroenterological Association

Completed

Point-of-care Anorectal Testing to Predict Outcomes With Biofeedback Therapy: Clinical Trial

Constipation

United States
Tel-Aviv Sourasky Medical Center

Unknown

Dental Support Device During Breastfeeding as a Mean for Pain Control

Breastfeeding
Lifetech Scientific (Shenzhen) Co., Ltd.
IQVIA Biotech

Active, not recruiting

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study (LISA)

Atrial Fibrillation

China, Denmark, Germany, Ireland, Italy, Poland, Spain, Sweden, Thailand
Medtronic Cardiovascular

Terminated

Talent Converter Post-Approval Study

Abdominal Aortic Aneurysms
Neurovalens Ltd.
University College Dublin; Exploristics Ltd; Compliance Solutions Ltd.

Completed

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

Obesity | Overweight | Metabolic Syndrome | Overweight and Obesity | Overweight or Obesity

Ireland
Shanghai Zhongshan Hospital

Recruiting

The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)

Atrial Septal Defect

China
Tel-Aviv Sourasky Medical Center

Unknown

Dental Support and the Second Stage of Labor Among Multiparous Women

Second Stage of Labor
atHeart Medical

Recruiting

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)

Heart Diseases | Cardiovascular Diseases | Congenital Abnormalities | Heart Septal Defects, Atrial | Heart Defects, Congenital | Cardiovascular Abnormalities | Heart Septal Defect

United States, France
Xijing Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Not yet recruiting

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology (RECORD)

Non-valvular Atrial Fibrillation

China
Occlutech International AB

Completed

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Patent Ductus Arteriosus

Malaysia, Vietnam
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder (PFO)

Patent Foramen Ovale

Ireland, Germany
Abbott Medical Devices
Japanese society of Congenital Interventional Cardiology

Recruiting

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Patent Ductus Arteriosus

Japan
Abbott Medical Devices

Active, not recruiting

Amplatzer PFO Occluder Post-marketing Surveillance Study (PFO PMS Jpn)

PFO - Patent Foramen Ovale

Japan

Search clinical trials for: Septal Occluder Device

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations